The U.S. Department of Health and Human Services (HHS) on Wednesday terminated a $766 million contract with Moderna for developing an mRNA-based vaccine against potential pandemic viruses, including H5N1 bird flu, which included $176 million awarded in July 2024 and $590 million in January 2025.
Trump Admin Cancels $766M Moderna Bird Flu Vaccine Contract